Navigation Links
Kyphon Stockholders Approve Merger with Medtronic
Date:10/16/2007

r diagnosing the source of low back pain, and in the Interspinous Process Decompression (IPD(R)) procedure for treating the symptoms of lumbar spinal stenosis. More information about the company and its products can be found at http://www.kyphon.com and its balloon kyphoplasty patient education Web site, http://www.spinalfracture.com.

Kyphon and IPD are registered trademarks, and Functional Anaesthetic Discography and F.A.D. are trademarks, of Kyphon Inc.

Forward-Looking Statements

This press release contains forward-looking statements, within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, about the completion of the merger. Forward-looking statements are based on management's current preliminary expectations and are subject to risks, uncertainties and assumptions, which may cause Kyphon's actual results to differ materially from the statements contained herein. Factors that could cause actual results to differ materially from management's current expectations include, without limitation, the potential inability to obtain the regulatory clearances required to complete the merger, or to do so in a timely manner, and the possibility that other conditions to completion of the merger may not be satisfied. Additional factors that may affect future results are contained in Kyphon's periodic filings with the SEC, which are available at the SEC's Web site http://www.sec.gov. Kyphon undertakes no obligation to release publicly any revisions to any forward-looking statements contained herein to reflect events or circumstances after the date hereof.

KYPHG


'/>"/>
SOURCE Kyphon Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. UW-Madison approves new research institute
2. FDA approves GEs heart-imaging technology
3. Senate approves bill to expand stem cell funding
4. FDA approves advanced digital mammography system
5. Building commission approves Institutes for Discovery
6. Seven good reasons to approve the Institutes for Discovery
7. Genzyme acquistion of Bone Care approved, significant impact forecast
8. UW Board of Regents approves $134 million medical research facility
9. FDA approves Bone Cares Hectorol for treatment of kidney disease
10. Technology and mergers: Getting the strategic applications
11. AT&T - BellSouth merger: Revestiture continues
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... 27, 2014 Rhythm, a biopharmaceutical company developing ... that result in metabolic disorders, announced today that it ... the U.S. Securities and Exchange Commission (SEC) relating to ... common stock. The number of shares to be offered ... yet been determined. Citigroup and Cowen and ...
(Date:8/27/2014)...   MSC , a healthcare performance improvement company ... appointment of Mary Beth Loesch to President ... experience preparing companies for rapid growth and market expansion, ... of Corporate Development and Healthcare. In that role, she ... well as corporate strategy and marketing. Previously, Loesch served ...
(Date:8/27/2014)... , Aug. 27, 2014 Reportlinker.com announces ... in its catalogue: Global Chelating Agents ... About Chelating Agent A chelating agent ... bonds with metal ions, thereby forming a metal-ion ... metal-ions have on chemical processes, formulations, and the ...
(Date:8/27/2014)... MADISON, N.J. , Aug. 27, 2014 /PRNewswire/ ... significant potential to help physicians better identify early-stage ... progression and disability, according to a new study ... from Quest Diagnostics (NYSE: DGX ) ... of the 14-3-3eta protein outperformed conventional antibody-serum testing, ...
Breaking Biology Technology:Rhythm Files Registration Statement for Proposed Initial Public Offering 2MSC names Mary Beth Loesch President and CEO 2Global Chelating Agents Market 2014-2018 2Global Chelating Agents Market 2014-2018 3Global Chelating Agents Market 2014-2018 4Novel Biomarker Detects Early Rheumatoid Arthritis Better than Conventional Methods Alone, According to Journal of Rheumatology Study 2Novel Biomarker Detects Early Rheumatoid Arthritis Better than Conventional Methods Alone, According to Journal of Rheumatology Study 3Novel Biomarker Detects Early Rheumatoid Arthritis Better than Conventional Methods Alone, According to Journal of Rheumatology Study 4
... COUNTY, Calif., April 28 Beckman Coulter, Inc. (NYSE: ... manufacturer and marketer of products that simplify, automate and ... March 31, 2009 results. For the first quarter, ... in constant currency terms. On a constant currency ...
... SHPGY ), the global specialty biopharmaceutical company, announces that at its,Annual General Meeting today, all resolutions contained in the ... ... Against Withheld**, 1. To receive the, ... together with the, director,s and, ...
... CITY, April 28 /PRNewswire-FirstCall/ - Medicago Inc. (TSX-V: ... effective and affordable vaccines based on proprietary manufacturing ... it has received a genetic sequence of the ... recently been identified in USA and Mexico, and ...
Cached Biology Technology:Beckman Coulter Announces First Quarter 2009 Results 2Beckman Coulter Announces First Quarter 2009 Results 3Beckman Coulter Announces First Quarter 2009 Results 4Beckman Coulter Announces First Quarter 2009 Results 5Beckman Coulter Announces First Quarter 2009 Results 6Beckman Coulter Announces First Quarter 2009 Results 7Beckman Coulter Announces First Quarter 2009 Results 8Beckman Coulter Announces First Quarter 2009 Results 9Beckman Coulter Announces First Quarter 2009 Results 10Beckman Coulter Announces First Quarter 2009 Results 11Beckman Coulter Announces First Quarter 2009 Results 12Beckman Coulter Announces First Quarter 2009 Results 13Beckman Coulter Announces First Quarter 2009 Results 14Beckman Coulter Announces First Quarter 2009 Results 15Beckman Coulter Announces First Quarter 2009 Results 16Beckman Coulter Announces First Quarter 2009 Results 17Beckman Coulter Announces First Quarter 2009 Results 18Beckman Coulter Announces First Quarter 2009 Results 19Beckman Coulter Announces First Quarter 2009 Results 20Beckman Coulter Announces First Quarter 2009 Results 21Beckman Coulter Announces First Quarter 2009 Results 22Beckman Coulter Announces First Quarter 2009 Results 23Beckman Coulter Announces First Quarter 2009 Results 24Beckman Coulter Announces First Quarter 2009 Results 25Beckman Coulter Announces First Quarter 2009 Results 26Beckman Coulter Announces First Quarter 2009 Results 27Beckman Coulter Announces First Quarter 2009 Results 28Beckman Coulter Announces First Quarter 2009 Results 29Shire plc: Results of the Annual General Meeting Held on April 28, 2009 2Medicago initiates work on Swine Flu strain 2
(Date:8/27/2014)... DURHAM, N.C. -- When we want to listen carefully ... talking. The second thing we do is stop moving ... unwanted sounds generated by our own movements. , This ... deep in the brain. Indeed, indirect evidence has long ... somehow influences the auditory cortex, which gives rise to ...
(Date:8/27/2014)... release is available in German . ... is the most common inherited disease affecting the peripheral ... the Max Planck Institute of Experimental Medicine and University ... Schwann cells is impaired in rats with the disease. ... layer known as myelin, which facilitates the rapid transfer ...
(Date:8/27/2014)... fishing traps are lost or abandoned each year in ... traps, which continue to catch fish, crabs, and other ... to habitat, fisheries, and the watermen who depend on ... newly published NOAA study. , The report, published in ... of its kind to examine the derelict fish trap ...
Breaking Biology News(10 mins):Stop and listen: Study shows how movement affects hearing 2Stop and listen: Study shows how movement affects hearing 3Potential therapy for incurable Charcot-Marie-Tooth disease 2NOAA's Marine Debris Program reports on the national issue of derelict fishing traps 2
... DC Fascinating scientific advances across the spectrum ... be featured and explained through engaging table-top exhibits ... 15th Annual Exhibition & Reception. The exhibition/reception will ... March 24, in Rooms B338-340 of the Rayburn ...
... Alzheimer,s disease drugs currently studied in clinical trials appears ... animals, researchers at Georgetown University Medical Center report in ... . They say the results suggest that this ... drug has been able to do-- prevent the long-term ...
... Researchers at Memorial Sloan-Kettering Cancer Center (MSKCC) have shown ... some blood disorders may be inherited. Their research, published ... common genetic sequence abnormality that enhances the likelihood of ... blood diseases. The investigators carried out a genome-wide ...
Cached Biology News:Science returns to the Capitol Hill spotlight at March 24 exhibition 2Science returns to the Capitol Hill spotlight at March 24 exhibition 3Science returns to the Capitol Hill spotlight at March 24 exhibition 4Alzheimer's disease therapeutic prevents long-term damage from TBI in pre-clinical studies 2Alzheimer's disease therapeutic prevents long-term damage from TBI in pre-clinical studies 3
TNF-R2 (L-20)...
50 assays. Provides an easy system for rapid separation of cytosol and particulate fractions that are compatiable with downstream studies....
Highly sensive assay for detecting apoptosis in living cells. See detailed descriptions above in K250-25....
Eliminate electrical interference from any analog signal, without filtering. Ideal for electrophysiology applications like EKG, EMG, and EEGs. Removes 50/60hz noise and harmonics caused by grounding ...
Biology Products: